Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model

last updated: 2023-01-02
ProjectBREAST-IT: Boosting Research Against Solid Tumor-Immunocompetence Tackling :: publications list
TitleFibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model
Publication TypePapers in Scientific Journals
Year of Publication2022
AuthorsIaia I., Brancato V., Caballero D., Reis R. L., Aglietta M., Sangiolo D., and Kundu S. C.
EditorsGuiseppi-Elie A.

Adoptive cell therapy in solid tumors, such as melanoma, is impaired, but little is known about the role that the fibroblasts present in the tumor microenvironment could exert. However, the mechanism at play is not well understood, partly due to the lack of relevant pre-clinical models. Three-dimensional culture and microfluidic chips are used to recapitulate the dynamic interactions among different types of cells in the tumor microenvironment in controlled and physiological settings. In this brief report, we propose a reductionist melanoma-on-a-chip model for evaluating the essential role of fibroblasts in the antitumor activity of lymphocytes. To this end, 3D melanoma spheroids were monocultured and co-cultured with human dermal fibroblasts and the NK-92 cell migration towards the tumor compartment was tested in a commercially available microfluidic device. Utilizing confocal microscopy, we observed the different recruitment of NK-92 cells in the presence and absence of fibroblasts. Our results show that fibroblasts’ presence inhibits immune effector recruiting by exploiting a 3D pre-clinical tumor model.

Date Published2022-12-30
KeywordsCancer, microfabrication, Microfluidics, Organ-on-a-chip
Peer reviewedyes

Back to top